David P Ryan

发表

Polyclonal Secondary FGFR2 Mutations Drive Acquired Resistance to FGFR Inhibition in Patients with FGFR2 Fusion-Positive Cholangiocarcinoma.

Gad Getz, Ignaty Leshchiner, Dejan Juric, 2017, Cancer discovery.

Phase I clinical trial of recombinant human endostatin administered as a short intravenous infusion repeated daily.

Donald W Kufe, Jeffrey W. Clark, J. Folkman, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Locally advanced pancreatic cancer.

Christopher G Willett, C. Willett, D. Ryan, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.

Lipika Goyal, Christopher H Crane, Edgar Ben-Josef, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Understanding the Paradigm Shift in Pancreatic Cancer.

D. Ryan, T. Hong, Theodore S Hong, 2016, Journal of oncology practice.

Phase II study of gemcitabine and oxaliplatin in combination with bevacizumab in patients with advanced hepatocellular carcinoma.

Alona Muzikansky, Keith Stuart, Jeffrey W. Clark, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Efficacy, safety, and potential biomarkers of sunitinib monotherapy in advanced hepatocellular carcinoma: a phase II study.

Marek Ancukiewicz, Vivek Sindhwani, Onofrio A Catalano, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer

Ricky T. Tong, Christopher G Willett, Jeffrey W. Clark, 2004, Nature Medicine.

Molecular Alterations in Tumors and Response to Combination Chemotherapy with Gefitinib for Advanced Colorectal Cancer

Shuji Ogino, Jeffrey W. Clark, Massimo Loda, 2005, Clinical Cancer Research.

RNA sequencing of pancreatic circulating tumour cells implicates WNT signaling in metastasis

Sridhar Ramaswamy, Mehmet Toner, Min Yu, 2012, Nature.

Epidermal Growth Factor Receptor Kinase Domain Mutations in Esophageal and Pancreatic Adenocarcinomas

Janusz Jankowski, David Ferry, Patricia L. Harris, 2006, Clinical Cancer Research.

Capecitabine plus erlotinib in gemcitabine-refractory advanced pancreatic cancer.

Alona Muzikansky, Colleen Lawrence, Jeffrey W. Clark, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II study of recombinant human endostatin in patients with advanced neuroendocrine tumors.

John V Heymach, Thomas J Lynch, J. Meyerhardt, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

NCCN Clinical Practice Guidelines in Oncology: rectal cancer.

Christopher Willett, Michael A Choti, Krystyna Kiel, 2009, Journal of the National Comprehensive Cancer Network : JNCCN.

T3N0 rectal cancer: radiation for all?

D. Ryan, T. Hong, H. Mamon, 2011, Seminars in radiation oncology.